Connect Biopharma Holdings Ltd ADR (CNTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,398 | -55,480 | -40,371 | -23,171 | -10,272 |
| Depreciation Amortization | 164 | 704 | 523 | 344 | 173 |
| Accounts receivable | 13 | 776 | 772 | 789 | 781 |
| Accounts payable and accrued liabilities | 2,342 | 1,622 | 1,652 | 1,952 | 475 |
| Other Working Capital | 2,037 | 526 | -2,245 | -1,113 | -587 |
| Other Operating Activity | -1,163 | 646 | -287 | -1,351 | -529 |
| Operating Cash Flow | $-16,005 | $-51,206 | $-39,956 | $-22,550 | $-9,959 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,000 | 10,250 | -750 | -15,130 | -20,562 |
| PPE Investments | N/A | -432 | -416 | -382 | -79 |
| Investing Cash Flow | $6,000 | $9,818 | $-1,166 | $-15,512 | $-20,641 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 137 | 1,093 | 378 | 163 | 2 |
| Other Financing Activity | 17,485 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $17,622 | $1,093 | $378 | $163 | $2 |
| Exchange Rate Effect | 72 | 408 | 357 | 299 | 75 |
| Beginning Cash Position | 38,345 | 78,232 | 78,232 | 78,232 | 78,232 |
| End Cash Position | 46,034 | 38,345 | 37,845 | 40,632 | 47,709 |
| Net Cash Flow | $7,689 | $-39,887 | $-40,387 | $-37,600 | $-30,523 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,005 | -51,206 | -39,956 | -22,550 | -9,959 |
| Capital Expenditure | N/A | -434 | -418 | -384 | -81 |
| Free Cash Flow | -16,005 | -51,640 | -40,374 | -22,934 | -10,040 |